We are live on ! Find out more
BCPEM

Bain Capital Public Equity Management Portfolio holdings

AUM $1.05B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
AUM
$1.42B
AUM Growth
-$66.6M
Cap. Flow
-$162M
Cap. Flow %
-11.45%
Top 10 Hldgs %
61.63%
Holding
89
New
26
Increased
10
Reduced
24
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 37.23%
2 Industrials 25.82%
3 Consumer Discretionary 14.11%
4 Healthcare 10.79%
5 Communication Services 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGMO
76
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-140,992
Closed -$2M
SPY icon
77
State Street SPDR S&P 500 ETF Trust
SPY
$810B
-7,542
Closed -$2.15M
SRPT icon
78
Sarepta Therapeutics
SRPT
$1.81B
-73,800
Closed -$9.76M
VRTX icon
79
Vertex Pharmaceuticals
VRTX
$133B
-241,408
Closed -$41M
PACW
80
DELISTED
PacWest Bancorp
PACW
-167,521
Closed -$8.28M
CLVS
81
DELISTED
Clovis Oncology, Inc.
CLVS
-50,541
Closed -$2.3M
GBT
82
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
-435
Closed -$524K
SAIL
83
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
-100,689
Closed -$2.47M
ALXN
84
DELISTED
Alexion Pharmaceuticals
ALXN
-70,753
Closed -$8.78M
NTGN
85
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
-11,706
Closed -$147K
MDCO
86
DELISTED
Medicines Co
MDCO
-52,807
Closed -$1.94M
WP
87
DELISTED
Worldpay, Inc.
WP
-174,001
Closed -$14.2M
ARRY
88
DELISTED
Array Biopharma Inc
ARRY
-130,844
Closed -$2.2M
ATVI
89
DELISTED
Activision Blizzard
ATVI
-268,928
Closed -$20.5M

Similar funds

Bain Capital Public Equity Management's Q3 2018 Portfolio in Review

As of Q3 2018, Bain Capital Public Equity Management held 89 positions worth $1.42B, down 4.5% from $1.48B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Bain Capital Public Equity Management withdrew a net $162M in Q3 2018, closing 25 positions and reducing 24 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 42% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bain Capital Public Equity Management opened a new position in Caterpillar worth $88.6M.

  • Bain Capital Public Equity Management's largest Q3 2018 buy was Caterpillar: 581,215 shares worth $88.6M.
  • Bain Capital Public Equity Management added most to Novartis in Q3 2018, an estimated $29.4M increase.
  • Bain Capital Public Equity Management's biggest Q3 2018 reduction was DocuSign, cutting an estimated $57.8M.
  • Bain Capital Public Equity Management fully exited Vertex Pharmaceuticals in Q3 2018, selling an estimated $41M.
  • Bain Capital Public Equity Management's ten largest holdings make up 62% of its $1.42B portfolio in Q3 2018.
  • Bain Capital Public Equity Management opened 26 new positions and closed 25 in Q3 2018.
  • Bain Capital Public Equity Management's portfolio value fell 4.5% quarter-over-quarter to $1.42B.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.